Philip Coelho

Philip Coelho

Directeur Général chez
Synergenesis, Inc.
82 ans
Health Technology
Consumer Services
Technology Services

Profil

Philip H.
Coelho
is the founder of ThermoGenesis Holdings, Inc. (1986), SynGen, Inc. (1999), and Thermogenesis Corp.
(1986).
He held the titles of Chairman & Chief Executive Officer at ThermoGenesis Holdings, Inc., Chief Technology Officer at SynGen, Inc., and Chief Technology Architect at Thermogenesis Corp.
Mr. Coelho's current jobs include President & Chief Executive Officer at Synergenesis, Inc. and Member at Society of Cryobiology.
His former jobs include President & Chief Executive Officer at PHC Medical, Inc. (2008-2009), Independent Director at WellSky Corp.
(2008-2012), Director at WellSky Corp.
(2001-2006), Independent Director at Catalyst Pharmaceuticals, Inc. (2011-2023), Lead Independent Director at Ampio Pharmaceuticals, Inc. (2010-2022), and Member-Supervisory Board at Kourion Therapeutics.
Mr. Coelho's education history includes an undergraduate degree from the University of California, Davis.

Postes actifs de Philip Coelho

SociétésPosteDébut
Society of Cryobiology
Corporate Officer/Principal -
Directeur Général -

Anciens postes connus de Philip Coelho

SociétésPosteFin
CATALYST PHARMACEUTICALS, INC. Directeur/Membre du Conseil 22/08/2023
AMPIO PHARMACEUTICALS, INC. Directeur/Membre du Conseil 28/05/2022
Fondateur 01/07/2017
Directeur/Membre du Conseil 01/12/2012
PHC Medical, Inc.
Directeur Général 01/10/2009
Voir l'expérience en détail de Philip Coelho

Formation de Philip Coelho

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

56

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Technology Services

Health Technology

Health Technology

Commercial Services

Finance

Consumer Services

PHC Medical, Inc.

Society of Cryobiology

Consumer Services

Health Technology

Electronic Technology

Producer Manufacturing

Health Technology

  1. Bourse
  2. Insiders
  3. Philip Coelho